Davis Blaine 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Award
Common Stock
2026-01-02+37,000→ 131,811 total - Award
Employee Stock Option (right to buy)
2026-01-02+109,000→ 109,000 totalExercise: $6.76Exp: 2036-01-01→ Common Stock (109,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2027. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2030.
- [F2]This option vests as to 25% on January 2, 2027. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.